ATRNL1: Mitochondrial Function and Disease (G26033)

Target Name: ATRNL1

NCBI ID: G26033

ATRNL1

ATRNL1: Mitochondrial Function and Disease

ATRNL1 (BA338L11.1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Shared Gene Family (SPG), which is a family of transmembrane proteins that are involved in a variety of cellular processes. ATRNL1 is known for its role in the regulation of mitochondrial function and has been implicated in a number of neurological and cardiovascular diseases.

One of the key functions of ATRNL1 is its role in the regulation of mitochondrial function. Mitochondria are organelles that are responsible for generating the energy that cells require for their survival, and they are essential for the function of many cellular processes. The mitochondria are also involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to a variety of diseases, including neurodegenerative diseases.

ATRNL1 is involved in the regulation of mitochondrial function by a variety of mechanisms. It interacts with the protein known as mitofusin, which is a protein that is involved in the transfer of mitochondrial fusion particles from the cytoplasm to the mitochondria. Mitofusin is also known for its role in the regulation of mitochondrial fusion, which is the process by which new mitochondria are formed in the cytoplasm.

ATRNL1 is also involved in the regulation of mitochondrial function by interacting with the protein known as Parkin. Parkin is a protein that is involved in the regulation of mitochondrial function and is expressed in the brain, heart, and kidneys. It is thought to play a role in the regulation of mitochondrial fusion and the production of ROS.

In addition to its role in the regulation of mitochondrial function, ATRNL1 is also involved in the regulation of a variety of cellular processes. It is involved in the production of various signaling molecules, including TGF-β1, which is a growth factor that plays a role in the development and maintenance of tissues. It is also involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs.

ATRNL1 is also involved in the regulation of a variety of cellular processes, including the regulation of cell signaling pathways. It is involved in the regulation of the PI3K/Akt signaling pathway, which is a pathway that is involved in the regulation of cellular signaling pathways . This pathway is important for the regulation of a variety of cellular processes, including cell growth, differentiation, and survival.

In addition to its role in the regulation of cellular processes, ATRNL1 is also involved in the regulation of disease. It is thought to be involved in the development and progression of a variety of diseases, including neurodegenerative diseases. For example, studies have suggested that ATRNL1 may be involved in the development of Alzheimer's disease, a neurodegenerative disease that is characterized by the progressive loss of brain cells.

In conclusion, ATRNL1 (BA338L11.1) is a protein that is involved in a variety of cellular and molecular processes. It is a member of the resource sharing gene family and is thought to play a role in the regulation of mitochondrial function, as well as the regulation of cellular signaling pathways and disease. Further research is needed to fully understand the role of ATRNL1 in these processes and its potential as a drug target or biomarker.

Protein Name: Attractin Like 1

Functions: May play a role in melanocortin signaling pathways that regulate energy homeostasis

The "ATRNL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATRNL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets